ACTSI Investigator Dr. Ihab Hajjar in the News

Ihab Hajjar, MD, ACTSI investigator and associate professor of medicine in the Division of General Medicine and Geriatrics with a secondary appointment in the Department of Neurology.  His research focuses on the vascular contributions to cognitive decline and aging. In particular, he has been studying the role of hypertension and the related renin angiotensin system in both vascular cognitive impairments and Alzheimer ’s disease. Currently his research is funded by an NIH R01 grant to study the effect of using candesartan (i.e., Lisinopril) in the management of mild cognitive impairment. In his free time, he enjoys running, bike riding and photography.

Recent Publications:

“Roles of arterial stiffness and blood pressure in hypertension-associated cognitive decline in healthy adults.” Hypertension. 2016 Jan;67(1):171-5. Read more…

“Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to Alzheimer's disease.” J Am Geriatr Soc. 2015 Sep;63(9):1749-56. Read more...

“Association between angiotensin receptor blockers and longitudinal decline in tau in mild cognitive impairment.” JAMA Neurol. 2015 Sep;72(9):1069-70. Read more...

“Aldosterone, Cognitive Function, and Cerebral Hemodynamics in Hypertension and Antihypertensive Therapy.” Am J Hypertens. 2015 Mar;28(3):319-25. Read more…

“Apolipoprotein E, Carbon Dioxide Vasoreactivity, and Cognition in Older Adults: Effect of Hypertension.” J Am Geriatr Soc. 2015 Feb;63(2):276-81 Read more…

Recent Success:

Hajjar is principal investigator of a grant from the Alzheimer’s Drug Discovery Foundation entitled “Effect of candesartan on prodromal Alzheimer’s Disease and its related biomarkers.”

Hajjar co-principal investigator on an NIH RF1 grant from the National Institute on Aging entitled “The role of the renin-angiotensin-endothelial pathway in AD.” Read more…

Emory School of Medicine MilliPub Club
The MilliPub Club honors faculty who have published papers garnering 1,000 or more citations Read More

In the News:

Emory News Center | Study: Increased arterial stiffness is superior to blood pressure in predicting cognitive decline in healthy individuals
December 22, 2015

Atlanta Business Chronicle | Looking for answers
March 27, 2015

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?